Esbl

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 05.04.2021

Dieser Artikel auf Deutsch

Synonym(s)

Extended-spectrum-betalactamase; Extended-spectrum-ß-lactamase

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Acronym for "extended-spectrum-ß-lactamase", which stands for a specific form of extended resistance to antibiotics in bacteria. Mutations in the range of known ß-lactamases enable pathogens to develop resistance to penicillins, cephalosporins (including third-generation cephalosporins (e.g. ceftriaxone, cefotaxime, ceftazidime) and aztreonam. Furthermore, resistance is observed in gram-negative bacteria from the Enterobacteriaceae group, especially in E.coli and Klebsiella pneumoniae, Enterobacter, Citrobacter and Proteus. See also MRSA.

EtiologyThis section has been translated automatically.

Mutations in beta-lactamase genes. ESBLs are classified into nine groups based on their diversity:

  • TEM
  • SHV
  • CTX-M
  • PER
  • VEB
  • GES
  • TLA
  • BES
  • OXA.

The most common are OXA, TEM and SHV. Normally, the active site of β-lactamases contains the amino acid serine. The highly active metallo-β-lactamases have a zinc ion in the active site. An example of this are the New Delhi metallo-β-lactamases (NDM).

TherapyThis section has been translated automatically.

There are only a few antibiotics available for the treatment of ESBL-forming pathogens, e.g. carbapenem (imipenem or meropenem), tigecycline or colistin. The best clinical data are available for imipenem and meropenem.

Note(s)This section has been translated automatically.

In contrast to Gram-positive MRSA, ESBL-forming bacteria are Gram-negative germs (E-coli, Klebsiell and Serratia strains are affected), which are originally found in the human intestine as normal flora. Contaminations are most likely when handling faeces.

Notice! As a preventive measure, protective gowns should be worn when handling ESBL patients and consistent hand disinfection should be carried out. If ESBL occurs, it is advisable to take hygiene measures similar to those for MRSA.

LiteratureThis section has been translated automatically.

  1. Huggett S et al (2018) Antibiotics Primer 2018/2019 Asclepius, Medical Scientific Publishing Company. S.51-52

Authors

Last updated on: 05.04.2021